FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1963522142> ?p ?o ?g. }

• W1963522142 endingPage "281" @default.
• W1963522142 startingPage "278" @default.
• W1963522142 abstract "Loss of HBsAg is observed in only 3-4% of patients who receive interferon for chronic HBV+HCV hepatitis, and there are few reports of HBsAg loss induced by treatments other than interferon. We report a case of chronic HBV+HCV hepatitis, in which a positive outcome was achieved with a new therapeutic strategy. The patient was a 49-year-old Caucasian woman found to be HBsAg+ in 1978 and HCVAb+ in 1997. During 2000-2003, the patient had markedly increased AST/ALT, histology grade 5, stage 1 (Ishak) disease with HBsAg positivity, HBV-DNA 1,450 cp/mL, HCV-RNA 7.57x105 IU/mL (genotype 1b). In May 2003 she began a 48-week course of PEG-IFNα2b (80 μg/week) without ribavirin. The latter drug was not used because it had recently been observed that in some HBV/HCV-coinfected patients treated with the two drugs, the hepatic flares preceding the seroconversion to HBsAb caused fulminant liver failure. Neither the HBV and HCV infections responded to this treatment, but during follow-up the HBV-DNA dropped to 40 cp/mL and the patient presented persistently normal transaminase values (6th month) followed by loss of HBsAg (24th month) and the appearance of anti-HBs (36th month). By December 2008, the HBV negativity and HBsAg/anti-HBs seroconversion were well-established, but HCV replication persisted. The decision was therefore made to administer PEG-IFNα2a (180 μg/week) and ribavirin (1,000 mg/day). There was no evidence of an RVR or EVR, so therapy was continued for 48 weeks. At the scheduled 12-month treatment, the patient was found to be HCV-RNA negative by TaqMan PCR. In our opinion this case is of great interest because: 1) it is the first report of a virological response in a HBV/HCV-coinfected CH patient treated with PEG-IFN; 2) control of the two viral infections was achieved with a new therapeutic strategy that included two phases: a) HBV-DNA loss at 6 months and HBsAg/anti-HBs seroconversion between months 24 and 36, after PEG-IFNα2b mono-therapy, which was administered when the HCV replication seemed to prevail over that of HBV; b) ETR for HCV after 72 weeks of PEG-IFNα2a+ribavirin, which was continued in spite of the lack of an EVR, as this does not preclude the possibility of a SVR." @default.
• W1963522142 created "2016-06-24" @default.
• W1963522142 creator A5008278922 @default.
• W1963522142 creator A5018240440 @default.
• W1963522142 creator A5068081029 @default.
• W1963522142 creator A5072875018 @default.
• W1963522142 creator A5090617378 @default.
• W1963522142 date "2011-12-01" @default.
• W1963522142 modified "2023-09-27" @default.
• W1963522142 title "HBsAg loss with HBsAg/anti-HBs seroconversion and non-detectable HCV-RNA in a patient with chronic HBV e-minus/HCV hepatitis treated with two cycles of antiviral therapy" @default.
• W1963522142 cites W184425049 @default.
• W1963522142 cites W1970053808 @default.
• W1963522142 cites W1975884873 @default.
• W1963522142 cites W1985143492 @default.
• W1963522142 cites W1986492786 @default.
• W1963522142 cites W1989448136 @default.
• W1963522142 cites W2010509888 @default.
• W1963522142 cites W2027545702 @default.
• W1963522142 cites W2056648239 @default.
• W1963522142 cites W2062458071 @default.
• W1963522142 cites W2074732056 @default.
• W1963522142 cites W2087648288 @default.
• W1963522142 cites W2101032357 @default.
• W1963522142 cites W2112876622 @default.
• W1963522142 cites W2117380333 @default.
• W1963522142 cites W2124502911 @default.
• W1963522142 cites W2127685726 @default.
• W1963522142 cites W2137171353 @default.
• W1963522142 cites W2164385547 @default.
• W1963522142 cites W2166826446 @default.
• W1963522142 cites W2169631718 @default.
• W1963522142 cites W2169752861 @default.
• W1963522142 cites W4231124841 @default.
• W1963522142 cites W4237472114 @default.
• W1963522142 cites W4327849090 @default.
• W1963522142 doi "https://doi.org/10.1016/j.itjm.2011.07.013" @default.
• W1963522142 hasPublicationYear "2011" @default.
• W1963522142 type Work @default.
• W1963522142 sameAs 1963522142 @default.
• W1963522142 citedByCount "0" @default.
• W1963522142 crossrefType "journal-article" @default.
• W1963522142 hasAuthorship W1963522142A5008278922 @default.
• W1963522142 hasAuthorship W1963522142A5018240440 @default.
• W1963522142 hasAuthorship W1963522142A5068081029 @default.
• W1963522142 hasAuthorship W1963522142A5072875018 @default.
• W1963522142 hasAuthorship W1963522142A5090617378 @default.
• W1963522142 hasBestOaLocation W19635221421 @default.
• W1963522142 hasConcept C126322002 @default.
• W1963522142 hasConcept C159047783 @default.
• W1963522142 hasConcept C203014093 @default.
• W1963522142 hasConcept C2522874641 @default.
• W1963522142 hasConcept C2776408679 @default.
• W1963522142 hasConcept C2776461080 @default.
• W1963522142 hasConcept C2777410769 @default.
• W1963522142 hasConcept C2777451964 @default.
• W1963522142 hasConcept C2780040827 @default.
• W1963522142 hasConcept C2780593183 @default.
• W1963522142 hasConcept C71924100 @default.
• W1963522142 hasConcept C90924648 @default.
• W1963522142 hasConceptScore W1963522142C126322002 @default.
• W1963522142 hasConceptScore W1963522142C159047783 @default.
• W1963522142 hasConceptScore W1963522142C203014093 @default.
• W1963522142 hasConceptScore W1963522142C2522874641 @default.
• W1963522142 hasConceptScore W1963522142C2776408679 @default.
• W1963522142 hasConceptScore W1963522142C2776461080 @default.
• W1963522142 hasConceptScore W1963522142C2777410769 @default.
• W1963522142 hasConceptScore W1963522142C2777451964 @default.
• W1963522142 hasConceptScore W1963522142C2780040827 @default.
• W1963522142 hasConceptScore W1963522142C2780593183 @default.
• W1963522142 hasConceptScore W1963522142C71924100 @default.
• W1963522142 hasConceptScore W1963522142C90924648 @default.
• W1963522142 hasIssue "4" @default.
• W1963522142 hasLocation W19635221421 @default.
• W1963522142 hasOpenAccess W1963522142 @default.
• W1963522142 hasPrimaryLocation W19635221421 @default.
• W1963522142 hasRelatedWork W1506797373 @default.
• W1963522142 hasRelatedWork W1963522142 @default.
• W1963522142 hasRelatedWork W1986044171 @default.
• W1963522142 hasRelatedWork W1993273424 @default.
• W1963522142 hasRelatedWork W2058381089 @default.
• W1963522142 hasRelatedWork W2059888761 @default.
• W1963522142 hasRelatedWork W2064248292 @default.
• W1963522142 hasRelatedWork W2082200384 @default.
• W1963522142 hasRelatedWork W2096288449 @default.
• W1963522142 hasRelatedWork W2338136459 @default.
• W1963522142 hasVolume "5" @default.
• W1963522142 isParatext "false" @default.
• W1963522142 isRetracted "false" @default.
• W1963522142 magId "1963522142" @default.
• W1963522142 workType "article" @default.